1. Mujagic,
Zlata
[Author,Reprint Author; E-mail: h
mujagic@yahoo.com];Mujagic,
Hamza [Author].Importance of serum prolactin determination in metastatic
breastcancer patients [Article] Croatian Medical Journal. 45(2). April2004.
176-180.
2. Mujagic,Z.
[Reprint author]; Mujagic, H.[Reprint author;
E-mail:hmujagic@yahoo.com
]. Circulating levels
of prolactin as an indicator of effectiveness oftherapy in breast cancer
patients [Meeting] International Journal ofCancer Supplement.(13). 2002.
216.
3. Mujagic,Hamza
[Reprintauthor]; Chabner, Bruce A. [Author];
Mujagic,Zlata
[Author;E-mail:hmujagic@yahoo.com
.
Mechanisms
of action and potential therapeutic uses of thalidomide[Article] Croatian
Medical Journal. 43(3). June, 2002. 274-285.
4. MUJAGICH[Reprint
author]; MUJAGIC Z [Author]. DETECTION
OF PLEIOTROPIC DRUG RESISTANCE BY THE RAPIDIMMUNOFLUORESCENCE ASSAY OF DRUG
EFFECTS ON THE CELL SKELETON[Article] Oncology (Basel). 48(3). 1991.
202-209.
5. MUJAGICH[Reprint
author]; KRNJAJIC N [Author]; JEVRIC A [Author]. THE LEVELSAND RELATIONS OF
PROSTAGLANDINS IN PREGNANT AND NON-PREGNANTTUMOR-BEARING MICE [Article]
Journal of Cancer Research &Clinical Oncology. 115(4). 1989. 383-387.
6. KRNJACN [Reprint author]; JEVRIC A [Author]; KRNJAIC Z [Author];
FILIPOVICI [Author]; MUJAGICH[Author].
COMPARISON OF PGE-1 AND PGE-2 LEVELS IN PREGNANT SYNGENEICBALB-C MICE WITH
TRANSPLANTED FIBROSARCOMA [Book. Meeting] SINZINGER,H. AND K. SCHROER (ED.).
PROGRESS IN CLINICAL AND BIOLOGICALRESEARCH, VOL. 242. PROSTAGLANDINS IN
CLINICAL RESEARCH; 3RDINTERNATIONAL SYMPOSIUM ON PROSTAGLANDINS, BAD ISCHL,
AUSTRIA,SEPTEMBER 16-20, 1986. XXIII+501P. ALAN R. LISS, INC.: NEW YORK,
NEWYORK, USA. ILLUS. 1987. 119-122. Series Information: Progress inClinical
and Biological Research.
7.
MUJAGICH[Reprint
author]; SHACKNEY S E [Author]; SMITH C E [Author]; CHEN S S[Author].
QUANTITATIVE CHANGES IN SURFACE IMMUNOGLOBULIN EXPRESSIONIN WEHI-231
LYMPHOMA CELLS IN RELATION TO THEIR PROLIFERATIVE RATE[Article] Oncology
(Basel). 43(4). 1986. 237-242.
8.
MUJAGICH[Reprint
author]; CONGER B M [Author]; SMITH C A [Author]; OCCHIPINTIS J [Author];
SCHUETTE W H [Author]; SHACKNEY S E [Author]. SCHEDULEDEPENDENCE OF
VINCRISTINE LETHALITY IN SARCOMA 180 CELLS FOLLOWINGPARTIAL SYNCHRONIZATION
WITH HYDROXY UREA [Article] Cancer Research.43(8). 1983. 3598-3603.
9. MUJAGIC H[Reprint author];
CONGER B M [Author]; SMITH C A [Author]; OCCHIPINTIS J [Author]; SCHUETTE W
H [Author]; SHACKNEY S E [Author]. SCHEDULEDEPENDENCE OF VINCRISTINE
LETHALITY IN SARCOMA 180 CELLS FOLLOWINGPARTIAL SYNCHRONIZATION WITH HYDROXY
UREA [Article] Cancer Research.43(8). 1983. 3598-3603.
10. MUJAGICH[Reprint
author]; CHEN S-S [Author]; GEIST R [Author]; OCCHIPINTI S J[Author]; CONGER
B M [Author]; SMITH C A [Author]; SCHUETTE W H[Author]; SHACKNEY S E
[Author]. EFFECTS OF VINCRISTINE ON CELLSURVIVAL CELL CYCLE PROGRESSION AND
MITOTIC ACCUMULATION INASYNCHRONOUSLY GROWING SARCOMA 180 CELLS [Article]
Cancer Research.43(8). 1983. 3591-3597.
11. SCHUETTEW H [Reprint author]; CHEN S S [Author]; OCCHIPINTI S J [Author];MUJAGIC
HS [Author]; SHACKNEY S E [Author]. AUTOMATED RADIOAUTOGRAPHIC GRAINCOUNTING
CORRECTION FOR GRAIN OVERLAP [Article] Cell & TissueKinetics. 16(3). 1983.
221-228.
12. CONGERB [Reprint author]; OCCHIPINTI S J [Author];
MUJAGICH[Author];
SMITH C E [Author]; SCHUETTE W H [Author]; CHEN S S[Author]; SHACKNEY S E
[Author]. THE LETHAL AND SUBLETHAL EFFECTS OFVINCRISTINE IN SARCOMA 180
IN-VITRO [Meeting] Cell & TissueKinetics. 15(6). 1982. 674.
13. MUJAGICH[Reprint
author]; DESKOVIC M [Author]; MALENICA B [Author]; BISTROVICM [Author]; NOLA
P [Author]; KRUSIC J [Author]. THE SIGNIFICANCE OFTUBERCULIN IMMUNITY
TESTING IN CANCER PATIENTS [Article] Cellular &Molecular Biology (Oxford).
26(2). 1980. 111-122.
14.
MUJAGICH[Reprint
author]. IMMUNO THERAPY WITH BCG AN ATTEMPT ATSTANDARDIZATION OF METHODS
BASED ON OUR EXPERIENCE AND RESULTS[Article] Periodicum Biologorum. 82(2).
1980. 195-206.
15. MUJAGICH[Reprint
author]; KOLARIC K [Author]; MALENICA B [Author]; NOLA P[Author]. BCG IMMUNO
THERAPY IN PREVIOUSLY TREATED MALIGNANT MELANOMAPATIENTS [Article]
Biomedicine (Paris). 30(2). 1979. 95-102.
16. MALENICAB [Author];
MUJAGICH[Author];
KOLARIC K [Author]; RADETIC M [Author]; MARICIC Z [Author];ROGULJIC A
[Author]; ROGAN J [Author]; VUKAS D [Author]. BCG IMMUNOTHERAPY IN
METASTATIC MALIGNANT MELANOMA [Article] PeriodicumBiologorum. 78(SUPPL 1).
1976. 158-159.
17. MUJAGICH[Author];
MAZURAN R [Author]; MALENICA B [Author]; SILOBRCIC V[Author]. CLINICAL
DETECTION OF CELLULAR IMMUNITY IN-VITRO TOMELANOMA SPECIFIC ANTIGENS IN MAN
BY THE MONOCYTE SPREADINGINHIBITION TEST CORRELATION BETWEEN IN-VIVO AND IN-VITROIMMUNOLOGICAL
TEST PARAMETERS [Article] Periodicum Biologorum.78(SUPPL 1). 1976. 156-157.
18. ROGANJ [Author];
MUJAGICH[Author];
MALENICA B [Author]. LYMPHOCYTE CYTO TOXICITY TO MALIGNANTMELANOMA AND
CERVICAL CARCINOMA CELLS [Article] PeriodicumBiologorum. 78(SUPPL 1). 1976.
155-156.
19. MUJAGICH[Author];
NOLA P [Author]; MALENICA B [Author]; MARICIC Z [Author];ALLEGRETTI N
[Author]. IMMUNOLOGIC REACTIVITY IN COLO RECTALCARCINOMA PATIENTS WITH
SPECIAL REFERENCE TO THE NEW T-SCLASSIFICATION OF CARCINOMAS OF THE COLON
AND RECTUM [Article]Periodicum Biologorum. 78(SUPPL 1). 1976. 153-154.
20. MUJAGICH[Author];
KRUSIC J [Author]; DESKOVIC M [Author]; MALENICA B[Author]. IMMUNOLOGIC
REACTIVITY TO NONSPECIFIC ANTIGENS IN CERVICALCARCINOMA PATIENTS [Article]
Periodicum Biologorum. 78(SUPPL 1).1976. 151-153.
21. MAZURANR [Author];
MUJAGICH[Author];
MELENICA B [Author]; SILOBRCIC V [Author]. IN-VITRODETECTION OF CELLULAR
IMMUNITY TO MELANOMA ANTIGENS IN MAN BY THEMONOCYTE SPREADING INHIBITION
TEST [Article] International Journal ofCancer. 17(1). 1976. 14-20.
22. SILOBRCICV [Author]; MILAS L [Author];
MUJAGICH[Author].
EXPERIMENTAL LUNG METASTASES AS A TEST IN TUMOR IMMUNOLOGY[Book] DOLL, R.
AND I. VODOPIJA (ED.). IARC (INTERNATIONAL AGENCY FORRESEARCH ON CANCER)
SCIENTIFIC PUBLICATION, NO. 7. HOST ENVIRONMENTINTERACTIONS IN THE ETIOLOGY
OF CANCER IN MAN. PROCEEDINGS OF AMEETING. PRIMOSTEN, YUGOSLAVIA, AUG. 27 -
SEPT. 2, 1972. XIX+464P.ILLUS. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER:
LYON, FRANCE.(DIST BY WORLD HEALTH ORGANIZATION, GENEVA, SWITZERLAND.).
1973.411-417.
23. MILASL [Author]; MUJAGICH[Author].
THE EFFECT OF SPLENECTOMY ON FIBRO SARCOMA METASTASES INLUNGS OF MICE
[Article] International Journal of Cancer. 11(1). 1973.186-190.
24. MILASL [Author];
MUJAGICH[Author].
PROTECTION BY CORYNEBACTERIUM-PARVUM AGAINST TUMOR CELLSINJECTED INTRA
VENOUSLY [Article] Revue Europeenne d'Etudes Cliniqueset Biologiques. 17(5).
1972. 498-500.
